Virios Therapeutics, Inc.
VIRI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $8,485 | $6,400 | $4,563 |
| - Cash | $10,127 | $13,403 | $17,539 | $0 |
| + Debt | $120 | $187 | $191 | $0 |
| Enterprise Value | – | -$4,730 | -$10,947 | $4,563 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$15,744 | -$3,923 | -$4,430 | -$12,224 |
| % Margin | – | – | – | – |
| Net Income | -$15,745 | -$3,807 | -$12,182 | -$12,859 |
| % Margin | – | – | – | – |
| EPS Diluted | -8.2 | -1.99 | -8.45 | -12.35 |
| % Growth | -312.1% | 76.4% | 31.6% | – |
| Operating Cash Flow | -$3,273 | -$4,026 | -$4,683 | -$8,788 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3,273 | -$4,026 | -$4,683 | -$8,788 |